Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL543816 | 0.87 | CYP4F2 (0.35) | CYP4F2CYP4A11MMP8L3MBTL1 | |
| SCHEMBL9274852 | 0.80 | TDP1 (0.44) | L3MBTL1 | |
| SCHEMBL10930331 | 0.80 | CYP4F2 (0.37) | CYP4F2CYP4A11MMP8L3MBTL1 | |
| SCHEMBL7826828 | 0.78 | MMP8 (0.43) | MMP8L3MBTL1 | |
| SCHEMBL9275213 | 0.78 | MMP8 (0.41) | MMP8L3MBTL1 | |
| SCHEMBL8045727 | 0.78 | MMP8 (0.35) | CYP4F2CYP4A11MMP8 | |
| SCHEMBL5451691 | 0.76 | MAPT (0.37) | CYP4F2CYP4A11MMP8 | |
| SCHEMBL4335915 | 0.76 | MMP8 (0.37) | CYP4F2CYP4A11MMP8 | |
| SCHEMBL3133963 | 0.75 | CYP4F2 (0.36) | CYP4F2CYP4A11MMP8L3MBTL1 | |
| SCHEMBL1072447 | 0.75 | CYP4F2 (0.36) | CYP4F2CYP4A11MMP8L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0648212-B1 | BENZOXAZOLE AND BENZOTHIAZOLE DERIVATIVES AS PHARMACEUTICAL | SMITHKLINE BEECHAM PLC (GB) | 2001-10-24 | — | — | EP | disclosed |
| EP-1000938-A1 | Heterocyclic compounds as pharmaceuticals | SMITHKLINE BEECHAM PLC (GB) | 2000-05-17 | — | — | EP | disclosed |
| US-6048883-A | HYPOGLYCEMIC AGENT | SMITHKLINE BEECHAM P.L.C. (GB) | 2000-04-11 | — | — | US | disclosed |
| US-5869495-A | TREATMENT AND/OR PROPHYLAXIS OF HYPERGLYCAEMIA | SMITHKLINE BEECHAM P.L.C. (GB) | 1999-02-09 | — | — | US | disclosed |
| US-5827865-A | TREATMENT AND-OR PROPHYLAXIS OF HYPERGLYEMIA | SMITHKLINE BEECHAM P.L.C. (GB) | 1998-10-27 | — | — | US | disclosed |
| EP-0648212-A1 | HETEROCYCLIC COMPOUNDS AS PHARMACEUTICAL | SMITHKLINE BEECHAM PLC (GB) | 1995-04-19 | — | — | EP | disclosed |
| WO-1994001420-A1 | HETEROCYCLIC COMPOUNDS AS PHARMACEUTICAL | SMITHKLINE BEECHAM PLC (GB) | 1994-01-20 | — | — | WO | disclosed |